Abstract
Patients with atrial fibrillation (AF) frequently also have CAD or other indications for aspirin. We aim to define the efficacy and safety of apixaban in patients with AF who are taking and not taking aspirin. ARISTOTLE included 18,201 patients randomized to apixaban 5 mg twice daily or warfarin.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
